Lista de obras -

A Novel Panel of Serum Biomarkers for MPM Diagnosis.

artículo científico publicado en 2017

A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.

artículo científico publicado en 2014

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma

artículo científico publicado en 2011

Analysis of survival at cardiac arrest in events occurred in work environments in the territory served by an operations center of the 118 of Tuscany

artículo científico publicado en 2020

Biomarkers in the prevention and follow-up of workers exposed to asbestos

artículo científico publicado en 2018

Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma

artículo científico publicado en 2011

Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament-related proteins

scientific article published on 12 February 2014

Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype

artículo científico publicado en 2016

Comparison between Plasma and Serum Osteopontin Levels: Usefulness in Diagnosis of Epithelial Malignant Pleural Mesothelioma ⬇️

artículo científico publicado el 1 de julio de 2010

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

artículo científico publicado en 2017

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

artículo científico publicado en 2017

Expression status of candidate genes in mesothelioma tissues and cell lines.

artículo científico publicado en 2014

Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.

artículo científico publicado en 2017

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

artículo científico publicado en 2014

Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.

artículo científico publicado en 2017

Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based study

artículo científico publicado en 2006

Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein

artículo científico publicado en 2010

Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.

artículo científico publicado en 2016

Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma

artículo científico publicado en 2020

Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome

scientific article published on 01 May 2020

Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.

artículo científico publicado en 2013

Rosiglitazone increases matrix production and quenches inflammation: studies in human cells.

artículo científico publicado en 2008

Serum mesothelin and other biomarkers: what have we learned in the last decade?

artículo científico publicado en 2018

Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma.

artículo científico publicado en 2016

Soluble Markers for Diagnosis of Malignant Pleural Mesothelioma ⬇️

artículo científico publicado el 1 de abril de 2011

TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.

artículo científico publicado en 2013

The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans

scientific article published on 10 May 2018

Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels

artículo científico publicado en 2011

Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide

scientific article published on 18 August 2020

Lista de obras de

A Novel Panel of Serum Biomarkers for MPM Diagnosis.

A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma

Analysis of survival at cardiac arrest in events occurred in work environments in the territory served by an operations center of the 118 of Tuscany

Biomarkers in the prevention and follow-up of workers exposed to asbestos

Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma

Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament-related proteins

Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype

Comparison between Plasma and Serum Osteopontin Levels: Usefulness in Diagnosis of Epithelial Malignant Pleural Mesothelioma ⬇️

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

Expression status of candidate genes in mesothelioma tissues and cell lines.

Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.

Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based study

Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein

Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.

Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma

Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome

Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.

Rosiglitazone increases matrix production and quenches inflammation: studies in human cells.

Serum mesothelin and other biomarkers: what have we learned in the last decade?

Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma.

Soluble Markers for Diagnosis of Malignant Pleural Mesothelioma ⬇️

TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.

The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans

Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels

Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide